FDA Orange Book · active-ingredient family
Loxapine
Loxapine is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ADASUVE · NDA 022549
1
Brand (NDA)
0
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · powder
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ADASUVERLD | NOVA PNEUMA | NDA 022549 | — | Dec 21, 2012 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8387612 | Oct 23, 2026 | in 4 mo | Product |
Loxapine — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
